Brind.

Diana Harshbarger, a Republican state senator from Tennessee, is linked to the FDA approving untested peptides for sale.

3 reports, 3 independent Updated Sep 11

Gone quiet

Reports: 3
Developments: 2
Repetition: 33%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 3 independent outlets

Diana Harshbarger, a Republican state senator from Tennessee, is linked to the FDA approving untested peptides for sale.

Who's involved

What this event is mainly about

Diana Harshbarger FDA

How it developed

Newest first. Tap a step to see who reported it.

Sep 11Harshbarger criticized FDA bureaucracy and Bass discussed the DSHEA framework.1 source
- nutraingredients.com
Jul 1TN Senator Diana Harshbarger linked to FDA approving untested peptides.1 source
- nationalmemo.com

Keep exploring

The entities involved

Diana Harshbarger
American pharmacist, businesswoman and politician (born 1960)

Nothing else this week.
FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56

Coverage

Newest first; wire copies grouped

Sep 11nutraingredients.com
Sep 2lawstreetmedia.com
Jul 1nationalmemo.comInside Kennedy's FDA: A Lawless, Reckless Rush To Approve Untested Peptides